Business

Rushnet, Inc. and its Subsidiaries Persist in the Climb Towards its Major Milestones and Goals

Rushnet, Inc. and its Subsidiaries Persist in the Climb Towards its Major Milestones and Goals.

articleRushnet, Inc.April 6, 20223/company/rushnet-inc/news/rushnet-inc-and-its-subsidiaries-persist-in-the-climb-towards-its-major-milestones-and-goals
Rushnet, Inc. and its Subsidiaries Persist in the Climb Towards its Major Milestones and Goals

About this update from Rushnet, Inc.

[{"type":"text","content":"ALPHARETTA, GA / ACCESSWIRE / April 6, 2022 / Rushnet, Inc (OTC PINK:RSHN), (the "Company") is pleased to announce an update as it progresses toward its major milestones and goals.The audit will be completed shortly with minor adjustments. On the heels of receiving a positive response from the ongoing audit, the company is faced with a critical decision that must be made in order to avoid any negative effect to the greater vision and timeline of the company's goals.The Rushnet, Inc. of the past is long gone. However, remnants of its historical dealings still cling to the business that have posed challenges to current management as it navigates the public sector in pursuit of the long-term goals that we've set for the current Rushnet. Today, we have a completely new face, new management and new goals within the National Diagnostics Laboratory and the Healthcare Billing and Coding space which is operating today as heliosDX and Grandeza Healthcare. The services and objectives of today are completely different and have an ultimate goal of continuing the enhancement of shareholder value. As in life, a business can be presented with various paths to choose in order to stay the course and achieve its ultimate long-term vision. The company's (heliosDX and Grandeza Healthcare) goals have not changed: grow the business to $50 million in revenue in three years and thereby increase shareholder value. The company has not wavered from this target and aims to accomplish this vision. The main primary target on this long-term path has been to acquire another toxicology laboratory that we know will greatly benefit the business and its shareholders.The paths for moving forward sometimes become foggy and entangled in the historical "issues" that have been and become challenges in the midst of the forest through which we trek. However, management has known all along that the paths still ultimately lead to the main objective and its primary next step of the acquisition. With that picture painted, we would like to provide further details of the past few months which have led to hurdles which have forced a critical decision to ensure that we stay the course.The means for acquisition comes through funding that we seek in order to provide the steppingstone to the next level. The path has led us in initiating a reverse split which was ...

More updates from Rushnet, Inc.